Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Illumina Unveils CEO Transition Plan | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Illumina Unveils CEO Transition Plan

Charles Dadswell replaces Francis deSouza as CEO.

By: Anthony Vecchione

Illunina Inc., a company involved in DNA sequencing and array-based technologies, named Charles Dadswell interim CEO. Dadswell has been serving as senior vice president and general counsel.

The company’s board of directors accepted the resignation of Francis deSouza, Sunday, June 11. deSouza will stay on in an advisory capacity until July 31, 2023.

“We thank Francis for his contributions and leadership and are very excited about embarking on the next chapter of Illumina’s great journey,” said Stephen MacMillan, chair of the board of Illumina. “Illumina’s technology remains at the forefront of DNA sequencing and has continued to set the pace for the industry. We are confident Illumina can continue to execute on its goals while we conduct and complete a CEO search process.”

In a statement, the company said that the board of directors is conducting a search for a new CEO looking at internal and external candidates. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics